| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 81, 2023-2026, Copyright © 1996 by Endocrine Society
ARTICLES |
N de Roux, M Polak, J Couet, J Leger, P Czernichow, E Milgrom and M Misrahi
INSERM U135 Hormones et Reproduction et laboratoire d'Hormonologie et Biologie Moleculaire, Hopital de Bicetre, Kremlin-Bicetre, France.
Until recently, neonatal hyperthyroidism has been considered to be related to the transplacental passage of thyroid-stimulating Ig present in the serum of the mother. We report here the case of a newborn who presented with severe hyperthyroidism, diffuse goiter, and important ocular signs (eyelid retraction and possibly proptosis). However, the absence of thyroid pathology in the parents and the lack of antithyroid antibodies in the mother and in the patient led us to suspect a nonimmune aetiology. Direct genomic sequencing of the last exon of the TSH receptor in the patient revealed a T-->C transversion yielding to a Met453-->Thr heterozygous substitution in the second transmembrane domain of the receptor. The mutation was absent in both parents. Eukaryotic expression analysis in COS-7 cells yielded a mutated receptor that produced constitutive activation of adenylate cyclase without enhancement of phospholipase C activity.
This article has been cited by other articles:
![]() |
G. Gelwane, N. de Roux, D. Chevenne, J. C. Carel, and J. Leger Pituitary-Thyroid Feedback in a Patient with a Sporadic Activating Thyrotropin (TSH) Receptor Mutation: Implication That Thyroid-Secreted Factors Other Than Thyroid Hormones Contribute to Serum TSH Levels J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2787 - 2791. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hebrant, J. Van Sande, P. P. Roger, M. Patey, M. Klein, C. Bournaud, F. Savagner, J. Leclere, J. E. Dumont, W. C. G. van Staveren, et al. Thyroid Gene Expression in Familial Nonautoimmune Hyperthyroidism Shows Common Characteristics with Hyperfunctioning Autonomous Adenomas J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2602 - 2609. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, G. Baker, D. Janus, C. A. Paddon, D. Fuhrer, and M. Ludgate Biological Effects of Thyrotropin Receptor Activation on Human Orbital Preadipocytes Invest. Ophthalmol. Vis. Sci., December 1, 2006; 47(12): 5197 - 5203. [Abstract] [Full Text] [PDF] |
||||
![]() |
S G Watson, A D Radford, A Kipar, P Ibarrola, and L Blackwood Somatic mutations of the thyroid-stimulating hormone receptor gene in feline hyperthyroidism: parallels with human hyperthyroidism J. Endocrinol., September 1, 2005; 186(3): 523 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Karges, G. Krause, J. Homoki, K.-M. Debatin, N. de Roux, and W. Karges TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5 J. Endocrinol., August 1, 2005; 186(2): 377 - 385. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, M. D. Lewis, F. Alkhafaji, K. Starkey, R. Paschke, D. Wynford-Thomas, M. Eggo, and M. Ludgate Biological Activity of Activating Thyroid-Stimulating Hormone Receptor Mutants Depends on the Cellular Context Endocrinology, September 1, 2003; 144(9): 4018 - 4030. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Ogilvy-Stuart Neonatal thyroid disorders Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2002; 87(3): F165 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Biebermann, T. Schoneberg, C. Hess, J. Germak, T. Gudermann, and A. Gruters The First Activating TSH Receptor Mutation in Transmembrane Domain 1 Identified in a Family with Nonautoimmune Hyperthyroidism J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4429 - 4433. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Ho, J. Van Sande, A. Lefort, G. Vassart, and S. Costagliola Effects of Mutations Involving the Highly Conserved S281HCC Motif in the Extracellular Domain of the Thyrotropin (TSH) Receptor on TSH Binding and Constitutive Activity Endocrinology, July 1, 2001; 142(7): 2760 - 2767. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Persani, A. Lania, L. Alberti, R. Romoli, G. Mantovani, S. Filetti, A. Spada, and M. Conti Induction of Specific Phosphodiesterase Isoforms by Constitutive Activation of the cAMP Pathway in Autonomous Thyroid Adenomas J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2872 - 2878. [Abstract] [Full Text] |
||||
![]() |
B. Buckingham The Hyperthyroid Fetus and Infant NeoReviews, June 1, 2000; 1(6): e103 - 109. [Full Text] |
||||
![]() |
D. H. C. Khoo, J. Parma, C. Rajasoorya, S. C. Ho, and G. Vassart A Germline Mutation of the Thyrotropin Receptor Gene Associated with Thyrotoxicosis and Mitral Valve Prolapse in a Chinese Family J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1459 - 1462. [Abstract] [Full Text] |
||||
![]() |
A. Grüters, T. Schöneberg, H. Biebermann, H. Krude, H. P. Krohn, H. Dralle, and T. Gudermann Severe Congenital Hyperthyroidism Caused by a Germ-Line neo Mutation in the Extracellular Portion of the Thyrotropin Receptor J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1431 - 1436. [Abstract] [Full Text] |
||||
![]() |
P. Wonerow, T. Schoneberg, G. Schultz, T. Gudermann, and R. Paschke Deletions in the Third Intracellular Loop of the Thyrotropin Receptor. A NEW MECHANISM FOR CONSTITUTIVE ACTIVATION J. Biol. Chem., April 3, 1998; 273(14): 7900 - 7905. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Paschke and M. Ludgate The Thyrotropin Receptor in Thyroid Diseases N. Engl. J. Med., December 4, 1997; 337(23): 1675 - 1681. [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, P. Wonerow, H. Willgerodt, and R. Paschke Identification of a New Thyrotropin Receptor Germline Mutation (Leu629Phe) in a Family with Neonatal Onset of Autosomal Dominant Nonautoimmune Hyperthyroidism J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4234 - 4238. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Fuhrer, H.-P. Holzapfel, P. Wonerow, W. A. Scherbaum, and R. Paschke Somatic Mutations in the Thyrotropin Receptor Gene and Not in the Gs{alpha} Protein Gene in 31 Toxic Thyroid Nodules J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3885 - 3891. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Parma, L. Duprez, J. Van Sande, J. Hermans, P. Rocmans, G. Van Vliet, S. Costagliola, P. Rodien, J. E. Dumont, and G. Vassart Diversity and Prevalence of Somatic Mutations in the Thyrotropin Receptor and Gs{alpha} Genes as a Cause of Toxic Thyroid Adenomas J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2695 - 2701. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Clifton-Bligh, J. W. Gregory, M. Ludgate, R. John, L. Persani, C. Asteria, P. Beck-Peccoz, and V. K. K. Chatterjee Two Novel Mutations in the Thyrotropin (TSH) Receptor Gene in a Child with Resistance to TSH J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1094 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Esapa, S. Foster, S. Johnson, J. L. Jameson, P. Kendall-Taylor, and P. E. Harris G Protein and Thyrotropin Receptor Mutations in Thyroid Neoplasia J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 493 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Duprez, J. Hermans, J. Van Sande, J. E. Dumont, G. Vassart, and J. Parma Two Autonomous Nodules of a Patient with Multinodular Goiter Harbor Different Activating Mutations of the Thyrotropin Receptor Gene J. Clin. Endocrinol. Metab., January 1, 1997; 82(1): 306 - 308. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |